How is Crigler-Najjar syndrome diagnosed?

TL;DR: Crigler-Najjar syndrome is primarily diagnosed through a combination of clinical assessment, elevated unconjugated bilirubin levels in blood tests, and confirmatory genetic testing to identify mutations in the UGT1A1 gene. Because this is a rare condition, diagnosis often involves ruling out other forms of liver disease or hemolytic anemia to confirm the specific deficiency of the bilirubin-glucuronosyltransferase enzyme.

How is Crigler-Najjar syndrome diagnosed?

The diagnostic journey for Crigler-Najjar syndrome often begins when an infant presents with persistent, unexplained jaundice shortly after birth. Because the condition is exceptionally rare, many families endure a long "diagnostic odyssey," moving between pediatricians and general practitioners before reaching a specialist. Diagnosis is typically a multi-step process involving biochemical analysis and molecular confirmation.

What tests are used to identify the condition?

To establish a diagnosis of Crigler-Najjar syndrome, physicians utilize a specific set of clinical investigations to distinguish it from other neonatal hyperbilirubinemias:

• Serum Bilirubin Tests: Blood work will show high levels of unconjugated (indirect) bilirubin, typically ranging from 6 to 25 mg/dL in Type I and lower in Type II, with no evidence of hemolysis.


• Liver Function Tests: These are performed to ensure that liver enzymes (AST, ALT) are normal, which helps rule out hepatitis or other primary liver damage.


• Genetic Testing: This is the gold standard. A molecular genetic test analyzes the UGT1A1 gene to identify the specific mutations responsible for the enzyme deficiency.


• Phenobarbital Response Test: Historically, doctors used this to distinguish between Type I and Type II. Patients with Type II typically show a significant decrease in bilirubin levels after a course of phenobarbital, whereas those with Type I do not.

What are the diagnostic criteria and differential diagnoses?

The diagnostic criteria for Crigler-Najjar syndrome rely on the absence of conjugated bilirubin in the bile and the specific quantitative deficiency of the UGT1A1 enzyme. It is essential to differentiate this condition from other disorders, such as Gilbert syndrome (which is much milder), hemolytic anemias, biliary atresia, and neonatal hepatitis. Because Crigler-Najjar syndrome is so rare, it is common for initial symptoms to be misattributed to breast milk jaundice or common neonatal jaundice, delaying appropriate intervention.

Which specialists are involved in the diagnostic process?

Given the complexity of Crigler-Najjar syndrome, diagnosis is best managed by a pediatric hepatologist or a metabolic disease specialist. These experts are familiar with the subtle clinical markers that differentiate the two types of the syndrome. If you are struggling to get a diagnosis, do not hesitate to seek a second opinion at a major academic medical center or a hospital specializing in pediatric liver disorders. The 35 members of the Crigler-Najjar syndrome community on DiseaseMaps.org often highlight the importance of finding a physician who listens to your concerns and understands the rarity of this metabolic condition.

Next steps

• Consult a pediatric hepatologist or a metabolic specialist to review your or your child's clinical history.


• Request a referral for genetic testing to identify the specific UGT1A1 mutation.


• Join the Crigler-Najjar syndrome community on DiseaseMaps.org to connect with others who have navigated the diagnostic process.


• Keep a detailed log of bilirubin levels and treatments to share with your medical team.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Crigler-Najjar syndrome overview.


• Orphanet: Rare disease database entry for Crigler-Najjar syndrome.


• OMIM (Online Mendelian Inheritance in Man): UGT1A1 gene and Crigler-Najjar syndrome entries.


• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Liver and metabolic disorder resources.